Schonfeld Strategic Advisors LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1665241 NEW YORK, NY

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,176,235

-$1,751,510 QoQ

Shares Held

28,607

-63.3% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#118

of 299 holders

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. RYTM ranks #38 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,176,235	28,607	-63.3%	Shares	Sole	2026-08-14
2025-06-30	$4,927,745	77,983	+36.5%	Shares	Sole	2025-08-14
2025-03-31	$3,027,235	57,150	-4.3%	Shares	Sole	2025-05-15
2024-12-31	$3,342,006	59,700	+95.5%	Shares	Sole	2025-02-14
2024-09-30	$1,599,728	30,535	+179.6%	Shares	Sole	2024-11-14
2024-06-30	$448,416	10,921	-18.0%	Shares	Sole	2024-08-14
2023-03-31	$237,468	13,311	-89.0%	Shares	Sole	2023-05-15
2022-12-31	$3,514,463	120,689	+146.8%	Shares	Sole	2023-02-14
2022-09-30	$1,198,123	48,903	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.